Kingmed Diagnostics, a leading independent medical laboratory based in Guangdong, has entered into a strategic partnership with GenStar Biosolutions Co., Ltd, a Beijing-headquartered specialist in immune diagnostic technology. The collaboration aims to jointly develop auto-antibody immunofluorescence AI interpretation software and create an integrated, intelligent immunofluorescence detection platform. Financial details of the agreement were not disclosed.
Kingmed Diagnostics, known for its cervical cancer intelligent screening workstation and immunofluorescence AI-assisted diagnostic system, will leverage its expertise alongside GenStar’s comprehensive R&D and production technology system in the field of immune diagnosis technology.- Flcube.com
